Ranbaxy drops nearly 3% on recall of Atorvastatin from US - The New Indian Express

Ranbaxy drops nearly 3% on recall of Atorvastatin from US

Published: 23rd November 2012 02:18 PM

Last Updated: 23rd November 2012 02:18 PM

Ranbaxy Laboratories, one of the leading pharma players, plunged nearly 3% on Friday after it has recalled Atorvastatin from the USA market. This will cause temporary disruption to that market of this product, it said.

''The investigation with regard to the same of this issue is expected to be completed within two weeks and thereafter the company expects to resume supplies,'' the company said. Shares ofthe companyare trading at Rs 498, down Rs 14.7, or 2.87% at the Bombay Stock Exchange (BSE) on Friday at 1:22 p.m.The scrip has touched an intra-day high of Rs 514.95 and low of Rs 495.60. The total volume of shares traded at the BSE is 113,773.In the earlier session, the shares declined 0.92%, or Rs 4.75, at Rs 512.70. Currently, the stock is trading down 13.89% from its 52-week high of Rs 578.30 and above 35.88% over the 52-week low of Rs 366.50.

Share Price Movement Period Pricein Rs Gain/(Loss) in Rs in % 1 Week 521.35 (8.65) (1.66) 1 Month 540.00 (27.30) (5.06) 3 Months 549.80 (37.10) (6.75) 6 Months 530.30 (17.60) (3.32) 1 Year 428.95 83.75 19.52 Note: Based on previous day closing price.

Disclaimer: We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the NIE editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.


Recent Activity

Pinterest Google Plus Twitter Facebook tumblr RSS Mobile Site apple Newshunt